IVF
INVO Fertility Inc (IVF)
Healthcare • NASDAQ • $1.72-5.49%
- Symbol
- IVF
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $1.72
- Daily Change
- -5.49%
- Market Cap
- $2.78M
- Trailing P/E
- N/A
- Forward P/E
- -0.07
- 52W High
- $277.20
- 52W Low
- $1.70
- Analyst Target
- $20.00
- Dividend Yield
- N/A
- Beta
- N/A
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INV…
Company websiteResearch IVF on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.